22088 Temsirolimus Statistical BPCA

First Page		Document Content
Macrolides Kidney cancer Temsirolimus Neuroblastoma Immunosuppressants Renal cell carcinoma Glioma Response Evaluation Criteria in Solid Tumors Sirolimus Medicine Oncology Brain tumor		22088 Temsirolimus Statistical BPCA Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 251,12 KB Share Document on Facebook

	1. Sautter BM, Wessely R, Bihl H. Comparison of systemic radiotherapy with I-131labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts. Strahlenther Onkol 1993;169:. DocID: 1ukO2 - View Document
	Numeric Key of Factor levels for extraction parameters Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development – A Systematic Review Marianne Isabelle Martic-Kehl, DocID: 1qWRv - View Document
	ANTI-TROPOMYOSIN AGENTS ENHANCE THE ANTITUMOR EFFECTIVENESS OF MICROTUBULE INHIBITORS IN PRECLINICAL MODELS OF NEUROBLASTOMA. JUSTINE STEHN1,2, MARK CURRIER3, DUO CHEN3, BROOKE NARTKER3, ELEANOR EIFFE1, ANDREW HEATON1,2, DocID: 1qUPq - View Document
	www.edoriumjournals.com CASE REPORT PEER REVIEWED \| OPEN ACCESS DocID: 1qNSk - View Document
	May 2016 29th April, 2015 INVESTOR FACT SHEET Business Summary Novogen is a drug development company focused on DocID: 1qNjw - View Document